Keywords: novartis, seeks, us/eu, approval, glivec, switzerland, filed

Novartis seeks US/EU approval for Glivec

Article | 01 March 2001

Print This

Switzerland's Novartis has filed regulatory submissions in the USA andEuropean Union for Glivec (imatinib mesylate), its new drug for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in